(Q51148228)

31 March 2018

https://api.crossref.org/works/10.1038/2251259B0

title

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid (English)

1 reference

17 May 2023

0 references

H. M. van Praag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5435360

17 May 2023

J. Korf

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5435360

17 May 2023

J. Puite

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5435360

17 May 2023

language of work or name

English

0 references

publication date

1 March 1970

1 reference

31 March 2018

28 March 1970

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5435360

full work available at URL

17 May 2023

http://www.nature.com/articles/2251259b0

1 reference

https://api.crossref.org/works/10.1038/2251259B0

http://www.nature.com/articles/2251259b0.pdf

17 May 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/2251259B0

17 May 2023

1 reference

31 March 2018

volume

225

1 reference

31 March 2018

issue

5239

1 reference

31 March 2018

page(s)

1259-1260

1 reference

31 March 2018

https://scigraph.springernature.com/pub.10.1038/2251259b0

exact match

0 references

cites work

The biochemistry of affective disorders

1 reference

7 January 2021

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

1 reference

7 January 2021

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

1 reference

7 January 2021

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

1 reference

7 January 2021

THE SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION AS AN ANTIDEPRESSIVE PRINCIPLE. I

1 reference

7 January 2021

Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine)

1 reference

7 January 2021

CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION

1 reference

7 January 2021

5-hydroxytryptophan for depression

1 reference

7 January 2021

Tryptophan in the treatment of depression.

1 reference

7 January 2021

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

1 reference

7 January 2021

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

7 January 2021

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

1 reference

7 January 2021

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

1 reference

7 January 2021

Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid

1 reference

7 January 2021

Identifiers

DOI

10.1038/2251259B0

1 reference

31 March 2018

Dimensions Publication ID

1050059299

0 references

1 reference

31 March 2018